Renaissance Capital logo

APMD News

Renaissance Capital’s July IPO Market Update

Apnimed logo

Eight IPOs raised a combined $29.3 billion in July, joined by three direct listings. New listings raised more than six times July’s 10-year historical average ($4.7B), driven almost entirely by Korea-listed SK hynix (SKHY), which raised $26.5 billion in ...read more

IPO Winners & Losers: Biotech Soars, Jersey Mike's Misses, and SpaceX Faces the Lockup

Apnimed logo

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market. Click here to get the newsletter in your inbox every week.

...read more

US IPO Weekly Recap: Jersey Mike’s and Reformation underwhelm

JMKE

Six IPOs and two SPACs priced this week. One IPO and one SPAC submitted filings. Sandwich chain Jersey Mike’s Subs (JMKE) priced at the midpoint to raise $1.0 billion at a $7.3 billion market cap. Backed by Blackstone, Jersey Mike's is a fast-casual...read more

Sleep apnea pill developer Apnimed prices upsized IPO at $16, the high end of the range

Apnimed logo

Apnimed, a late-stage drug developer advancing a pill for obstructive sleep apnea, raised $192 million by offering 12 million shares at $16, the high end of the $14 to $16 range. The company had originally filed to sell 10 million shares. Apnimed's sole...read more